Effect of Visuospatial Attention on the Sensorimotor Gating System

Abstract

The integration of multiple sensory modalities allows us to adapt to the environment of the outside world. It is widely known that visual stimuli interfere with the processing of auditory information, which is involved in the ability to pay attention. Additionally, visuospatial attention has the characteristic of laterality. It is unclear whether this laterality of visuospatial attention affects the processing of auditory stimuli. The sensorimotor gating system is a neurological process, which filters out unnecessary stimuli from environmental stimuli in the brain. Prepulse inhibition (PPI) is an operational measure of the sensorimotor gating system, which a weaker prestimulus (prepulse), such as a visual stimulus, inhibits the startle reflex elicited by a subsequent robust startling stimulus (pulse) such as a tone. Therefore, we investigated whether the visual stimulus from the left or right visual space affects the sensorimotor gating system in a “rest” task (low attentional condition) and a “selective attention” task (high attentional condition). In the selective attention task, we found that the target prepulse presented in the left and bilateral visual fields suppressed the startle reflex more than that presented in the right visual field. By contrast, there was no laterality of PPI in the no-target prepulse condition, and there was no laterality of PPI in the rest task. These results suggest that the laterality of visuospatial attention affects the sensorimotor gating system depending on the attentional condition. Moreover, the process of visual information processing may differ between the left and right brain.

Repeated noninvasive stimulation of the ventromedial prefrontal cortex reveals cumulative amplification of pleasant compared to unpleasant scene processing: A single subject pilot study

“…In this pilot study, we investigated how repeated vmPFC-tDCS across 5 days affects the previously reported modulation of valence specificity [14,15,27].…”

“…tDCS tDCS was applied by means of a DC Stimulator Plus (NeuroConn). The procedure was identical to previous studies [14,15,27]: in a two-electrode design with a 3 x 3 cm square electrode placed at 10-20 electrode position Fp and a 5 x 5 cm square electrode placed below the chin as extracephalic reference, a current strength of 1.5 mA was applied over 10 min. Both electrodes were covered in saline soaked sponges to enable sufficient conductibility.…”

“…If the cluster mass reached a p-value < .05 in comparison to the biggest cluster of each of the 1,000 permutations (cluster-level criterion), it surpassed the critical cluster mass and thus was considered significant. Cluster mass-analyses were conducted for previously determined intervals (see [14,15,27]) of 0-100 ms (early), 100-200 ms (early mid-latency), 200-300 ms (late mid-latency) and 300-600 ms (late). First-and second-level significant clusters that were cut off by the beginning or end of a pre-defined interval were reanalyzed in an interval extended for 50 ms in the respective direction.…”

Lipopolysaccharide Increases Cortical Kynurenic Acid and Deficits in Reference Memory in Mice

“…36 The assimilation of pooled sensory modalities allows us to adapt to various environments. 37 PPI is the ability of a nonstartling pulse to inhibit responding to a subsequent startling "pulse" or stimulus. Deficits in sensorimotor gating, as measured by PPI, are well described in patients diagnosed with SCZ and other psychiatric disorders.…”

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice

“…In vitro studies have shown that CBD dose-dependently inhibits tau hyperphosphorylation in Aβ-simulated PC12 cells ( Esposito et al, 2006a ). Furthermore, CBD can increase cell survival, reduce Aβ-induced lipid peroxidation and reactive oxygen species production ( Iuvone et al, 2004 ), attenuate nitric oxide ( Esposito et al, 2006b ), and counteract the elevation of APP expression in transfected human neuroblastoma cells, thereby increasing cell survival ( Scuderi et al, 2014 ). In vivo , CBD has been found to attenuate Aβ-evoked neuroinflammation in a pharmacological mouse model of AD ( Esposito et al, 2007 ).…”